These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6412492)

  • 21. Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa.
    Collins MS; Roby RE
    Am J Med; 1984 Mar; 76(3A):168-74. PubMed ID: 6424446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific and non-specific mouse protection induced by different chemotypes of the Pseudomonas aeruginosa lipopolysaccharides.
    Stanislavsky ES; Makarenko TA; Kozhenova TE
    FEMS Microbiol Immunol; 1992 Oct; 5(4):181-9. PubMed ID: 1419116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine against heterologous immunotype strains in a burned mouse model.
    Matthews-Greer JM; Gilleland HE
    J Infect Dis; 1987 Jun; 155(6):1282-91. PubMed ID: 3033095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective immunity induced in mice by immunization with high-molecular-weight polysaccharide from Pseudomonas aeruginosa.
    Pier GB; Sidberry HF; Sadoff JC
    Infect Immun; 1978 Dec; 22(3):919-25. PubMed ID: 103841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Protective artificial polysaccharide-protein antigens made from the O-specific polysaccharides of Pseudomonas aeruginosa bacteria of the immunotypes 1, 2 and 7].
    Kul'shin VA; Antsiferova NG; Moroz AF; Dmitriev BA
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Nov; (11):69-71. PubMed ID: 2464262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experimental immunological effectiveness and safety of pyoimmunogen vaccine against Pseudomonas aeruginosa infection].
    Stanislavskiĭ ES; Ioo I; Severtsova MK; Mashilova GM; Boltutsiĭ LG
    Zh Mikrobiol Epidemiol Immunobiol; 1982 May; (5):70-5. PubMed ID: 6808791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polysaccharide antigens of Pseudomonas aeruginosa.
    Knirel YA
    Crit Rev Microbiol; 1990; 17(4):273-304. PubMed ID: 1698385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TNF-alpha induction by Pseudomonas aeruginosa lipopolysaccharide or slime-glycolipoprotein in human monocytes is regulated at the level of Mitogen-activated Protein Kinase activity: a distinct role of Toll-like receptor 2 and 4.
    Lagoumintzis G; Xaplanteri P; Dimitracopoulos G; Paliogianni F
    Scand J Immunol; 2008 Feb; 67(2):193-203. PubMed ID: 18086260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antigenic properties of Pseudomonas aeruginosa anatoxin and the protective action of antitoxic anti-Pseudomonas aeruginosa serum].
    Podgornaia LG; Dziuban NF
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Jun; (6):67-9. PubMed ID: 3092510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa.
    Priebe GP; Walsh RL; Cederroth TA; Kamei A; Coutinho-Sledge YS; Goldberg JB; Pier GB
    J Immunol; 2008 Oct; 181(7):4965-75. PubMed ID: 18802100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection against fatal Pseudomonas aeruginosa sepsis by immunization with smooth and rough lipopolysaccharides.
    Cryz SJ; Meadow PM; Fürer E; Germanier R
    Eur J Clin Microbiol; 1985 Apr; 4(2):180-5. PubMed ID: 3924605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunochemical characterization of high-molecular-weight polysaccharide from Fisher immunotype 3 Pseudomonas aeruginosa.
    Pier GB; Pollack M; Cohen M
    Infect Immun; 1984 Aug; 45(2):309-13. PubMed ID: 6430805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation and characterization of a human monoclonal antibody that recognizes epitopes shared by Pseudomonas aeruginosa immunotype 1, 3, 4, and 6 lipopolysaccharides.
    Lang AB; Fürer E; Larrick JW; Cryz SJ
    Infect Immun; 1989 Dec; 57(12):3851-5. PubMed ID: 2509371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigenic epitope in Pseudomonas aeruginosa lipopolysaccharide immunologically cross-reactive with Escherichia coli O26 lipopolysaccharide.
    Yokota S; Kaya S; Noguchi H
    FEMS Microbiol Lett; 1990 Mar; 56(3):245-8. PubMed ID: 1692796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective activities of ribosomal ribonucleic acid and lipopolysaccharide of Pseudomonas aeruginosa: a comparative study.
    Gonggrijp R; Mullers WJ; van Boven CP
    Antonie Van Leeuwenhoek; 1983 Jun; 49(2):173-82. PubMed ID: 6193755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polyagglutinating and non-typable strains of Pseudomonas aeruginosa in cystic fibrosis.
    Pitt TL; MacDougall J; Penketh AR; Cooke EM
    J Med Microbiol; 1986 Mar; 21(2):179-86. PubMed ID: 2419563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smooth lipopolysaccharide is the major protective antigen for mice in the surface extract from IATS serotype 6 contributing to the polyvalent Pseudomonas aeruginosa vaccine PEV.
    MacIntyre S; Lucken R; Owen P
    Infect Immun; 1986 Apr; 52(1):76-84. PubMed ID: 3082762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Slime glycolipoproteins and the pathogenicity of various strains of Pseudomonas aeruginosa in experimental infection.
    Dimitracopoulos G; Bartell PF
    Infect Immun; 1980 Nov; 30(2):402-8. PubMed ID: 6777303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipopolysaccharide and high-molecular-weight polysaccharide serotypes of Pseudomonas aeruginosa.
    Pier GB; Thomas DM
    J Infect Dis; 1982 Feb; 145(2):217-23. PubMed ID: 6798136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.